Phase Ii Study Of Vinorelbine (V) And Docetaxel (D) As Second Line Therapy For Advanced Non-Small Cell Lung Cancer (Nsclc) Patients Resistant To Paclitaxel Or Gemcitabine-Platinum Based Regimens

INTERNATIONAL JOURNAL OF CANCER(2002)

Cited 0|Views18
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined